Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

EAU Guidelines on Renal Cell Carcinoma: The 2010 Update

(2010) Börje Ljungberg et al.   EUROPEAN UROLOGY

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

(2010) Cora N. Sternberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

(2009) Loukas F Kontovinis et al.   BMC CANCER

Is Hypothyroidism a Clinically Relevant Toxicity of Tyrosine Kinase Inhibitors?

(2009) Francesco Torino et al.   THYROID

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation

(2008) P Wolter et al.   BRITISH JOURNAL OF CANCER